GoodRx (GDRX) Earnings Date, Estimates & Call Transcripts → [Webinar] A Deep Dive into Options Volatility: Skew & Relative Value (From OIC) (Ad) Free gdrx Stock Alerts $6.58 -0.35 (-5.05%) (As of 12:16 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateAug. 14EstimatedActual EPS (Feb. 29) $0.02 Consensus EPS (Feb. 29) $0.02 Get GoodRx Earnings AlertsEnter your email address below to receive the latest news and earnings results for GDRX and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueGDRX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.GDRX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Stansberry ResearchDo This Today BEFORE Biden Wins in NovemberDiscover "U.S.'s New Money" Before Biden Wins A new form of money has emerged in America, and it's making some folks wildly rich… (Musk and Bezos both use it).Find out how you can too in this free video. GoodRx Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20241$0.04$0.04$0.04 Q2 20241$0.03$0.03$0.03 Q3 20241$0.03$0.03$0.03 Q4 20241$0.02$0.02$0.02 FY 20244$0.12$0.12 $0.12GDRX Earnings Date and InformationGoodRx last announced its earnings data on February 29th, 2024. The reported $0.02 earnings per share for the quarter, meeting the consensus estimate of $0.02. The business earned $196.64 million during the quarter, compared to the consensus estimate of $195.59 million. GoodRx has generated ($0.02) earnings per share over the last year (($0.02) diluted earnings per share). Earnings for GoodRx are expected to grow by 34.78% in the coming year, from $0.23 to $0.31 per share. GoodRx has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 14th, 2024 based off prior year's report dates.Read More GoodRx Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/14/2024Estimated)------- 2/29/2024Q4 2023$0.02$0.02-$0.10$195.59 million$196.64 million11/9/2023Q3 2023$0.06$0.06-$0.09$188.52 million$180.00 million 8/9/2023Q2 2023$0.01$0.02+$0.01($0.10)$186.90 million$189.68 million5/10/2023Q1 2023$0.01$0.01-$0.03$181.87 million$183.99 million2/28/2023Q4 2022($0.01)$0.01+$0.02$0.02$178.17 million$184.11 million8/8/2022Q2 2022($0.02)$0.02+$0.04$0.04$184.71 million$191.80 million Get the Latest News and Ratings for GDRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for GoodRx and its competitors with MarketBeat's FREE daily newsletter. 5/9/2022Q1 2022$0.02$0.03+$0.01$0.03$200.61 million$203.30 million 2/28/2022Q4 2021$0.03$0.01($0.02)$0.12$217.51 million$213.30 million 11/10/2021Q3 2021$0.01$0.09+$0.08$0.02$196.08 million$195.10 million 8/12/2021Q2 2021$0.01$0.08+$0.07($0.07)$174.15 million$176.64 million 5/13/2021Q1 2021$0.07$0.07-($0.02)$160.61 million$160.40 million GoodRx Earnings - Frequently Asked Questions When is GoodRx's earnings date? GoodRx has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 14th, 2024 based off last year's report dates. Learn more on GDRX's earnings history. Did GoodRx beat their earnings estimates last quarter? In the previous quarter, GoodRx (NASDAQ:GDRX) reported $0.02 earnings per share (EPS) to hit the analysts' consensus estimate of $0.02. Learn more on analysts' earnings estimate vs. GDRX's actual earnings. How much revenue does GoodRx generate each year? GoodRx (NASDAQ:GDRX) has a recorded annual revenue of $750.27 million. How much profit does GoodRx generate each year? GoodRx (NASDAQ:GDRX) has a recorded net income of -$8.87 million. GDRX has generated -$0.02 earnings per share over the last four quarters. What is GoodRx's price-to-earnings ratio? GoodRx (NASDAQ:GDRX) has a forward price-to-earnings ratio of 29.26. The price/earnings-to-growth ratio is 3.89. What is GoodRx's EPS forecast for next year? GoodRx's earnings are expected to grow from $0.23 per share to $0.31 per share in the next year, which is a 34.78% increase. More Earnings Resources from MarketBeat Related Companies: Arrowhead Pharmaceuticals Earnings Results Summit Therapeutics Earnings Results ACADIA Pharmaceuticals Earnings Results Olink Holding AB (publ) Earnings Results Certara Earnings Results RingCentral Earnings Results PROCEPT BioRobotics Earnings Results QuidelOrtho Earnings Results Life Time Group Earnings Results Azenta Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:GDRX) was last updated on 5/10/2024 by MarketBeat.com Staff From Our Partners[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICThis 1 Biotech Stock has been shocking the marketsHuge AlertsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaGold Set to EXPLODE!Gold Safe ExchangeYou need to know these two things about AI stocks ASAP…InvestorPlaceShocking: One AI startup's revenue could surge 4,735%Manward PressHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GoodRx Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
